Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study

A recent experimental study suggested that proton pump inhibitors (PPI), widely used to prevent gastroduodenal complications of dual antiplatelet therapy, may increase the accumulation of the endogenous nitric oxide synthesis antagonist asymmetric dimethylarginine (ADMA), an adverse outcome predicto...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruszelnicka, Olga, Świerszcz, Jolanta, Bednarek, Jacek, Chyrchel, Bernadeta, Surdacki, Andrzej, Nessler, Jadwiga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848910/
https://www.ncbi.nlm.nih.gov/pubmed/27092494
http://dx.doi.org/10.3390/ijms17040454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848910/
https://www.ncbi.nlm.nih.gov/pubmed/27092494
http://dx.doi.org/10.3390/ijms17040454

Ejemplares similares